| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 43 |
| 1 | OMEPRAZOLE MAGNESIUM | 23 |
| 2 | OMEPRAZOLE | 21 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 20 |
| 4 | PREDNISONE | 19 |
| 5 | ADALIMUMAB | 17 |
| 6 | PANTOPRAZOLE | 16 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 8 | TACROLIMUS OINTMENT 0.1% | 16 |
| 9 | VEDOLIZUMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOBARBITAL SODIUM | 2 | 0.0048 |
| 1 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 2 | DANTROLENE SODIUM | 2 | 0.0017 |
| 3 | SORBITOL | 1 | 0.0017 |
| 4 | MEBENDAZOLE | 1 | 0.0013 |
| 5 | VELAGLUCERASE ALFA | 2 | 0.0010 |
| 6 | PLERIXAFOR | 1 | 0.0007 |
| 7 | RAMELTEON | 5 | 0.0007 |
| 8 | AZILSARTAN KAMEDOXOMIL | 2 | 0.0007 |
| 9 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 4 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 5 | Melatonin Receptor Agonist [EPC] | 5 | 0.0004 |
| 6 | Anthelmintic [EPC] | 1 | 0.0003 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 8 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |